The GSK share price has had a rotten few years and now it's heading south yet again. Investor Harvey Jones continues to hang ...

Congress in Spain were a major feature of research news last week, including those from Pfizer on it ponsegromab in cancer ...

Everything we covered on WTR over the past seven days, and all you need to know from the world of trademarks to set yourself up for the start of another busy week.

This Fool wants to make the most of the benefits a Stocks and Shares ISA provides. He's keen on these two stocks.

GSK PLC GSK shares slipped 2.45% to £15.36 Friday, on what proved to be an all-around grim trading session for the stock ...

Topline results were announced from a phase 3 study assessing the immune response following coadministration of Arexvy and Shingrix.

Neuberg Diagnostics unveils 'Geniee', a personalised genomics platform offering genetic testing and tailored medicine for ...

Data science is one of the most current career choices today, especially in a data-driven world. Today, more businesses rely on data for making strategic decisi ...

Bank of America Securities analyst Graham Parry maintained a Sell rating on GlaxoSmithKline (GSK – Research Report) yesterday and set a ...

An Illinois mistrial involving the recalled medication Zantac is the latest court decision involving the recalled drug, but ...

If approved, the co-administration of Arexvy and Shingrix could provide a more convenient vaccination regimen for patients ...

Bone and Joint Health Supplement Market According to the Future Market Insights’ latest report, global sales of bone and ...